RAEB
Showing 1 - 25 of 54
Myelodysplastic Syndrome RAEB-I or RAEB-II, Refractory Acute Myeloid Leukemia, Refractory CML Myeloid Blast Crisis Trial in
Completed
- Myelodysplastic Syndrome RAEB-I or RAEB-II
- +2 more
- GM-CSF secreting leukemia vaccine
-
Boston, MassachusettsDana-Farber Cancer Institute
Jan 28, 2022
Myelodysplastic Syndrome, Allogeneic Hematopoietic Stem Cell Transplantation, Conditioning Trial in Guangzhou (Granulocyte
Recruiting
- Myelodysplastic Syndrome
- +2 more
- Granulocyte Colony-Stimulating Factor(G-CSF)
- +4 more
-
Guangzhou, Guangdong, ChinaDepartment of Hematology,Nanfang Hospital, Southern Medical Univ
Jan 15, 2021
Myelodysplastic Syndrome, Acute Myeloid Leukemia Trial in Tampa, Cleveland (Idarubicin, Cytarabine, Lenalidomide (Revlimid®))
Completed
- Myelodysplastic Syndrome
- Acute Myeloid Leukemia
- Idarubicin
- +2 more
-
Tampa, Florida
- +1 more
Dec 1, 2020
Myelodysplastic Syndrome (MDS) Trial run by the NHLBI (ON 01910 Na)
Completed
- Myelodysplastic Syndrome (MDS)
- ON 01910 Na
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 14, 2019
A Prospective, Multicentre European Registry for Newly Diagnosed
Recruiting
- Myelodysplastic Syndromes (MDS)
- No interventions
-
Innsbruck, Austria
- +17 more
Dec 28, 2020
Myelodysplastic Syndrome, MDS, Refractory Anemia With Excess Blasts Trial in Worldwide (rigosertib, Any approved or
Terminated
- Myelodysplastic Syndrome
- +3 more
- rigosertib
- +2 more
-
La Jolla, California
- +157 more
Sep 22, 2022
MDS Over Time - Comparison of Treated vs Untreated Patients
Completed
- Myelodysplastic Syndromes
-
Vienna, AustriaHanusch Krankenhaus, 3.Medizinische Abteilung
Nov 21, 2022
Acute Myeloid Leukemia Trial in Worldwide (hematopoietic cell transplantation, Non-Transplant treatment approach for
Terminated
- Acute Myeloid Leukemia
- hematopoietic cell transplantation
- Non-Transplant treatment approach for consolidation
-
Melbourne Victoria, Australia
- +47 more
Oct 6, 2021
Changing Over Time of Ascorbic Acid After Chemotherapy
Active, not recruiting
- Leukemia (Both ALL and AML)
- +2 more
- blood withdrawn
-
Maastricht, Limburg, NetherlandsMUMC+
Sep 23, 2021
MDS-EB Trial in Jinan (Allogeneic NK cell regimen group)
Not yet recruiting
- MDS-EB
- Allogeneic NK cell regimen group
-
Jinan, Shandong, ChinaThe 2nd Hospital of Shandong University
Oct 21, 2020
MDS Trial in Worldwide (Oral Azacitidine, Durvalumab)
Active, not recruiting
- Myelodysplastic Syndromes
- Oral Azacitidine
- Durvalumab
-
New Haven, Connecticut
- +65 more
Aug 19, 2022
MDS, MDS, RAEB Trial in Worldwide (ON 01910.Na)
Completed
- Myelodysplastic Syndromes
- +3 more
- ON 01910.Na
-
Scottsdale, Arizona
- +86 more
Jun 29, 2020
Myelodysplastic Syndrome, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in France, United States (oral
Completed
- Myelodysplastic Syndrome
- +2 more
- oral rigosertib
- Azacitidine
-
Gilbert, Arizona
- +12 more
Jun 15, 2021
Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia Trial in Australia, Canada, United States
Completed
- Acute Myelogenous Leukemia
- +4 more
- Single Umbilical Cord Blood Unit Transplant
- +6 more
-
Birmingham, Alabama
- +37 more
Oct 13, 2021
MDS, Refractory Anemia With Excess Blasts, Chronic Myelomonocytic Leukemia Trial in Worldwide (rigosertib sodium)
Completed
- Myelodysplastic Syndromes
- +3 more
- rigosertib sodium
-
Stanford, California
- +34 more
Jun 29, 2020
Leukemia, Myeloid, Acute, MDS, Leukemia, Myelomonocytic, Chronic Trial in Duesseldorf (Lenalidomide, Azacitidine, Donor
Completed
- Leukemia, Myeloid, Acute
- +2 more
- Lenalidomide
- +2 more
-
Duesseldorf, NRW, GermanyUniversity Hospital Duesseldorf, Dept. of Hematology, Oncology a
May 26, 2020
Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome-Refractory Anemia With Excess Blasts Trial in
Completed
- Acute Myeloid Leukemia
- +2 more
- GM-K562/leukemia cell vaccine
-
Boston, MassachusettsDana-Farber Cancer Institute
Sep 15, 2020
Acute Myeloid Leukemia, Myelodysplastic Syndrome, Multiple Myeloma Trial in Boston (CM-CS1 T-cell infusion)
Completed
- Acute Myeloid Leukemia
- +2 more
- CM-CS1 T-cell infusion
-
Boston, MassachusettsDana-Farber Cancer Institute
May 30, 2018
Hodgkin Lymphoma, Lymphocytic Leukemia, Mixed Cell Leukemia Trial run by the NCI (Stem cell transplantation)
Completed
- Hodgkin Lymphoma
- +8 more
- Stem cell transplantation
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 13, 2019
Chemotherapy vs No Chemotherapy Pre-transplant to MDS Undergoing
Unknown status
- Myelodysplastic Syndrome
- Chemotherapy
- Demethylation drug
- Chemotherapy regimen
-
Guangzhou, Guangdong, ChinaDepartment of Hematology,Nanfang Hospital, Southern Medical Univ
Dec 6, 2017
Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndrome Trial in
Completed
- Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative
- +13 more
- Cyclosporine
- +6 more
-
Salt Lake City, Utah
- +2 more
Jan 15, 2020